The University of Zurich is a public research university located in the city of Zürich, Switzerland. It is the largest university in Switzerland, with its 28,000 enrolled students. It was founded in 1833 from the existing colleges of theology, law, medicine which go back to 1525, and a new faculty of philosophy.

During the past decade, University of Zurich conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 4 clinical trials were completed, i.e. on average, 9.5% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 2 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Zurich" #1 sponsor was "University of Zurich" with 37 trials, followed by "Cytheris SA" with 3 trials sponsored, "CancerVax Corporation" with 2 trials sponsored, "Johns Hopkins University" with 2 trials sponsored and "University of Bern" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Zurich" #1 collaborator was "University of Zurich" with 7 trials as a collaborator, "Swiss National Science Foundation" with 4 trials as a collaborator, "University of Calgary" with 3 trials as a collaborator, "Cardiocentro Ticino" with 2 trials as a collaborator and "Foundation Wings For Life" with 2 trials as a collaborator. Other collaborators include 147 different institutions and companies that were collaborators in the rest 153 trials.

According to Clinical.Site data, the most researched conditions in "University of Zurich" are "Healthy" (5 trials), "Effect of High Altitude" (4 trials), "Spinal Cord Injury" (3 trials), "Chronic Disease" (2 trials) and "Depression" (2 trials). Many other conditions were trialed in "University of Zurich" in a lesser frequency.

Most popular intervention types in "University of Zurich" are "Other" (18 trials), "Drug" (12 trials), "Device" (11 trials), "Behavioral" (10 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Altitude exposure" (2 trials), "CancerVax vaccine (CANVAXIN)" (2 trials), "Exercise" (2 trials) and "Interleukin-7" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Zurich" are 63 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Zurich". 2 are not yet recruiting, 12 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in University of Zurich, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of Zurich, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 38 trials that are defined as “Not Applicable".